{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:11:38Z","timestamp":1793859098382,"version":"4.6.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","award":["CPU2018GF02"],"award-info":[{"award-number":["CPU2018GF02"]}],"id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK2011437"],"award-info":[{"award-number":["BK2011437"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012172","name":"Double First Class University Plan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773745"],"award-info":[{"award-number":["81773745"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejmech.2021.113933","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T22:59:53Z","timestamp":1634684393000},"page":"113933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Discovery and computational studies of 2-phenyl-benzoxazole acetamide derivatives as promising P2Y14R antagonists with anti-gout potential"],"prefix":"10.1016","volume":"227","author":[{"given":"Mengze","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongkui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2287-7685","authenticated-orcid":false,"given":"Yifan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1045-5466","authenticated-orcid":false,"given":"Qinghua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1487-6893","authenticated-orcid":false,"given":"Huanqiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113933_bib1","doi-asserted-by":"crossref","first-page":"7135","DOI":"10.1113\/JP274980","article-title":"Empowering human cardiac progenitor cells by P2Y14 nucleotide receptor overexpression","volume":"595","author":"Khalafalla","year":"2017","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.ejmech.2021.113933_bib2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/jpet.109.150730","article-title":"Gi-dependent cell signaling responses of the human P2Y14 receptor in model cell systems","volume":"330","author":"Fricks","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2021.113933_bib3","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/jpet.108.136309","article-title":"UDP is a competitive antagonist at the human P2Y14 receptor","volume":"325","author":"Fricks","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2021.113933_bib4","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1101\/gad.1071503","article-title":"P2Y-like receptor, GPR105 (P2Y14), identifies and mediates chemotaxis of bone-marrow hematopoietic stem cells","volume":"17","author":"Lee","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2021.113933_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1124\/jpet.102.036079","article-title":"Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats","volume":"303","author":"Okada","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2021.113933_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/pr.58.3.3","article-title":"International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy","volume":"58","author":"Abbracchio","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2021.113933_bib7","first-page":"36","article-title":"UDP-sugars activate P2Y14 receptors to mediate vasoconstriction of the porcine coronary artery, Vascul","volume":"103\u2013105","author":"Abbas","year":"2018","journal-title":"Pharma"},{"key":"10.1016\/j.ejmech.2021.113933_bib8","doi-asserted-by":"crossref","first-page":"108649","DOI":"10.1016\/j.abb.2020.108649","article-title":"Extracellular ATP modulates podocyte function through P2Y purinergic receptors and pleiotropic effects on AMPK and cAMP\/PKA signaling pathways","volume":"695","author":"Szrejder","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2021.113933_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/B978-0-12-391861-1.00009-5","article-title":"Probing GPCR structure: adenosine and P2Y nucleotide receptors","volume":"520","author":"Jacobson","year":"2013","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejmech.2021.113933_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0165-6147(02)00038-X","article-title":"Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family","volume":"24","author":"Abbracchio","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2021.113933_bib11","doi-asserted-by":"crossref","first-page":"69358","DOI":"10.18632\/oncotarget.12541","article-title":"Nucleoside 5'-O-monophosphorothioates as modulators of the P2Y14 receptor and mast cell degranulation","volume":"7","author":"Gendaszewska-Darmach","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2021.113933_bib12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.fsi.2019.07.053","article-title":"Functional characterization of purinergic receptor P2Y14 in the Japanese flounder (Paralichthys olivaceus) head kidney macrophages","volume":"93","author":"Li","year":"2019","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.ejmech.2021.113933_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.218","article-title":"The purinergic P2Y14 receptor axis is a molecular determinant for organism survival under in utero radiation toxicity","volume":"4","author":"Kook","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2021.113933_bib14","first-page":"G923","article-title":"UDP-glucose modulates gastric function through P2Y14 receptor-dependent and -independent mechanisms","volume":"296","author":"Bassil","year":"2009","journal-title":"Am. J. Physiol-Gastr. L"},{"key":"10.1016\/j.ejmech.2021.113933_bib15","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.4049\/jimmunol.171.4.1941","article-title":"Human immature monocyte-derived dendritic cells express the G protein-coupled receptor GPR105 (KIAA0001, P2Y14) and increase intracellular calcium in response to its agonist, uridine diphosphoglucose","volume":"171","author":"Skelton","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2021.113933_bib16","first-page":"L967","article-title":"cAMP and purinergic P2y receptors upregulate and enhance inducible NO synthase mRNA and protein in\u00a0vivo","volume":"273","author":"Greenberg","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejmech.2021.113933_bib17","first-page":"1181","article-title":"Adenosine 5'-(gamma-thio) triphosphate (ATPgammaS) stimulates both P2Y receptors linked to inositol phosphates production and cAMP accumulation in bovine adrenocortical fasciculata cells, Life","volume":"74","author":"Nishi","year":"2004","journal-title":"Sci"},{"key":"10.1016\/j.ejmech.2021.113933_bib18","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.bbrc.2015.03.121","article-title":"P2Y purinergic receptor-regulated insulin secretion is mediated by a cAMP\/Epac\/Kv channel pathway","volume":"460","author":"Zhang","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113933_bib19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41581-020-0300-y","article-title":"Targeting inflammation in AKI by P2Y14 receptor inhibition in mice","volume":"16","author":"Allison","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejmech.2021.113933_bib20","doi-asserted-by":"crossref","first-page":"21199","DOI":"10.1002\/jcp.28726","article-title":"P2Y14 receptor is functionally expressed in satellite glial cells and mediates interleukin-1beta and chemokine CCL2 secretion","volume":"234","author":"Lin","year":"2019","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.ejmech.2021.113933_bib21","first-page":"73","article-title":"The inflammatory effects of UDP-glucose in N9 microglia are not mediated by P2Y14 receptor activation, Purinerg","volume":"4","author":"Brautigam","year":"2008","journal-title":"Signal"},{"key":"10.1016\/j.ejmech.2021.113933_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121419","article-title":"Renal intercalated cells sense and mediate inflammation via the P2Y14 receptor","volume":"10","author":"Azroyan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2021.113933_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jep.2016.03.025","article-title":"Geniposide attenuates inflammatory response by suppressing P2Y14 receptor and downstream ERK1\/2 signaling pathway in oxygen and glucose deprivation-induced brain microvascular endothelial cells","volume":"185","author":"Li","year":"2016","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2021.113933_bib24","doi-asserted-by":"crossref","first-page":"104567","DOI":"10.1016\/j.neuint.2019.104567","article-title":"The P2Y14 receptor in the trigeminal ganglion contributes to the maintenance of inflammatory pain","volume":"131","author":"Lin","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejmech.2021.113933_bib25","doi-asserted-by":"crossref","first-page":"111564","DOI":"10.1016\/j.ejmech.2019.111564","article-title":"Design, synthesis and anti-inflammatory evaluation of 3-amide benzoic acid derivatives as novel P2Y14 receptor antagonists","volume":"181","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113933_bib26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pupt.2017.05.005","article-title":"Lipopolysaccharide (LPS) induced pulmonary neutrophil recruitment and platelet activation is mediated via the P2Y1 and P2Y14 receptors in mice","volume":"45","author":"Amison","year":"2017","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.ejmech.2021.113933_bib27","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bcp.2009.10.024","article-title":"UDP-glucose acting at P2Y14 receptors is a mediator of mast cell degranulation","volume":"79","author":"Gao","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113933_bib28","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1172\/JCI134791","article-title":"Proinflammatory P2Y14 receptor inhibition protects against ischemic acute kidney injury in mice","volume":"130","author":"Battistone","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2021.113933_bib29","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1021\/acsmedchemlett.0c00115","article-title":"P2Y14 receptor antagonists reverse chronic neuropathic pain in a mouse model","volume":"11","author":"Mufti","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113933_bib30","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3892\/mmr.2013.1429","article-title":"Polymorphisms in the NLRP3 gene and risk of primary gouty arthritis","volume":"7","author":"Meng","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejmech.2021.113933_bib31","first-page":"457","article-title":"Genetic variants of PPAR-gamma coactivator 1B augment NLRP3-mediated inflammation in gouty arthritis","volume":"56","author":"Chang","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejmech.2021.113933_bib32","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/rheumatology\/kex499","article-title":"Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation","volume":"57","author":"Yang","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejmech.2021.113933_bib33","first-page":"172","article-title":"NLRP3 inflammasome and lipid metabolism analysis based on UPLC-Q-TOF-MS in gouty nephropathy","volume":"44","author":"Zhang","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejmech.2021.113933_bib34","doi-asserted-by":"crossref","first-page":"580593","DOI":"10.3389\/fimmu.2020.580593","article-title":"Gallic acid alleviates gouty arthritis by inhibiting NLRP3 inflammasome activation and pyroptosis through enhancing Nrf2 signaling","volume":"11","author":"Lin","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2021.113933_bib35","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2174\/0929867327666200123093544","article-title":"Recent progress on the discovery of NLRP3 inhibitors and their therapeutic potential","volume":"28","author":"Su","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113933_bib36","first-page":"9230","article-title":"MiR-146a alleviates inflammation of acute gouty arthritis rats through TLR4\/MyD88 signal transduction pathway","volume":"23","author":"Chen","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2021.113933_bib37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jare.2020.02.007","article-title":"Discovery of novel and potent P2Y14R antagonists via structure-based virtual screening for the treatment of acute gouty arthritis","volume":"23","author":"Wang","year":"2020","journal-title":"J.\u00a0Adv. Res."},{"key":"10.1016\/j.ejmech.2021.113933_bib38","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.bmcl.2011.03.081","article-title":"The identification of 4,7-disubstituted naphthoic acid derivatives as UDP-competitive antagonists of P2Y14","volume":"21","author":"Gauthier","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113933_bib39","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/cb500614p","article-title":"Exploring a 2-naphthoic acid template for the structure-based design of P2Y14 receptor antagonist molecular probes","volume":"9","author":"Kiselev","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113933_bib40","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1021\/acs.jmedchem.6b00044","article-title":"Structure-based design of 3-(4-aryl-1H-1,2,3-triazol-1-yl)-Biphenyl derivatives as P2Y14 receptor antagonists","volume":"59","author":"Junker","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113933_bib41","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1021\/acs.jmedchem.8b00168","article-title":"Structure-guided modification of heterocyclic antagonists of the P2Y14 receptor","volume":"61","author":"Yu","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113933_bib42","doi-asserted-by":"crossref","first-page":"9563","DOI":"10.1021\/acs.jmedchem.0c00745","article-title":"Exploration of alternative scaffolds for P2Y14 receptor antagonists containing a biaryl core","volume":"63","author":"Jung","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113933_bib43","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1021\/acs.jmedchem.1c00164","article-title":"Structure-activity relationship of heterocyclic P2Y14 receptor antagonists: removal of the zwitterionic character with piperidine bioisosteres","volume":"64","author":"Jung","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113933_bib44","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1016\/j.bmc.2015.03.042","article-title":"Molecular modeling of the human P2Y(14) receptor: a template for structure-based design of selective agonist ligands","volume":"23","author":"Trujillo","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113933_bib45","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.bmc.2018.02.013","article-title":"Development of benzoxazole deoxybenzoin oxime and acyloxylamine derivatives targeting innate immune sensors and xanthine oxidase for treatment of gout","volume":"26","author":"Huang","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113933_bib46","series-title":"Schr\u00f6dinger, Version 9.0","year":"2009"},{"key":"10.1016\/j.ejmech.2021.113933_bib47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2021.113933_bib48","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1021\/mp100444g","article-title":"ADME evaluation in drug discovery. 9. Prediction of oral bioavailability in humans based on molecular properties and structural fingerprints","volume":"8","author":"Tian","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2021.113933_bib49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2015.01.009","article-title":"The application of in silico drug-likeness predictions in pharmaceutical research","volume":"86","author":"Tian","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2021.113933_bib50","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1021\/mp300198d","article-title":"Drug-likeness analysis of traditional Chinese medicines: prediction of drug-likeness using machine learning approaches","volume":"9","author":"Tian","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2021.113933_bib51","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1359-6446(97)01163-X","article-title":"Virtual screening - an overview","volume":"3","author":"Walters","year":"1998","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2021.113933_bib52","series-title":"Benzoxazole Derivatives as P2Y14 Inhibitors and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Hyperuricemia and Acute Gouty Arthritis in, China","author":"Li","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113933_bib53","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.bmcl.2004.01.023","article-title":"Synthesis and SAR of 2-arylbenzoxazoles, benzothiazoles and benzimidazoles as inhibitors of lysophosphatidic acid acyltransferase-beta","volume":"14","author":"Gong","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113933_bib54","doi-asserted-by":"crossref","first-page":"7664","DOI":"10.1021\/jm1008083","article-title":"Design and synthesis of 2-arylbenzimidazoles and evaluation of their inhibitory effect against Chlamydia pneumoniae","volume":"53","author":"Keurulainen","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113933_bib55","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.bmcl.2019.05.021","article-title":"Synthesis and biological evaluation of acylthiourea against DUSP1 inhibition","volume":"29","author":"Kim","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113933_bib56","series-title":"Preparation of Benzofuran Derivative as P2Y14 Receptor Inhibitor","author":"Hu","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113933_bib57","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/ejoc.201800374","article-title":"Palladium-catalyzed regioselective C-2 arylation of benzofurans with N-acyl arylhydrazines","volume":"2018","author":"Cao","year":"2018","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2021.113933_bib58","doi-asserted-by":"crossref","first-page":"17707","DOI":"10.1021\/ja409663q","article-title":"Transforming suzuki-miyaura cross-couplings of MIDA boronates into a green technology: No organic solvents","volume":"135","author":"Isley","year":"2013","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113933_bib59","article-title":"Structural optimization of aminopyrimidine-based CXCR4 antagonists","author":"Zhu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113933_bib60","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.113933_bib61","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejmech.2018.05.035","article-title":"Discovery of potent and novel smoothened antagonists via structure-based virtual screening and biological assays","volume":"155","author":"Lu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113933_bib62","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1021\/acs.jcim.7b00188","article-title":"Discovery of novel and selective adenosine A(2A) receptor antagonists for treating Parkinson's disease through comparative structure-based virtual screening","volume":"57","author":"Tian","year":"2017","journal-title":"J.\u00a0Chem. Inf. Model."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421007820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421007820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:34:02Z","timestamp":1759329242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421007820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":62,"alternative-id":["S0223523421007820"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113933","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and computational studies of 2-phenyl-benzoxazole acetamide derivatives as promising P2Y14R antagonists with anti-gout potential","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113933"}}